vs
Encompass Health Corp（EHC）とMosaic Company (The)（MOS）の財務データ比較。上の社名をクリックして会社を切り替えられます
Mosaic Company (The)の直近四半期売上が大きい（$3.0B vs $1.5B、Encompass Health Corpの約1.9倍）。Encompass Health Corpの純利益率が高く（9.5% vs -17.5%、差は26.9%）。Encompass Health Corpの前年同期比売上増加率が高い（9.9% vs 5.6%）。Encompass Health Corpの直近四半期フリーキャッシュフローが多い（$116.7M vs $-405.7M）。過去8四半期でEncompass Health Corpの売上複合成長率が高い（8.3% vs 5.3%）
エンコンパスヘルスコーポレーション（旧Amcare、HealthSouth）は米国アラバマ州バーミンガムに本社を置く米国最大の入院リハビリサービス事業者で、39州とプエルトリコに173の入院リハビリ病院を展開し、脳卒中や神経疾患、心肺疾患、脳損傷から回復中の患者に専門的な治療とケアを提供している。
ザ・モザイク・カンパニーは米国フロリダ州タンパに本社を置く化学企業で、リン鉱石・カリ鉱石の採掘、尿素の調達を行い、複数の国際流通網と傘下の肥料事業部を通じて肥料を生産・販売しており、米国最大のカリ肥料・リン酸肥料メーカーである。
EHC vs MOS — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $1.5B | $3.0B |
| 純利益 | $146.1M | $-519.5M |
| 粗利率 | — | 11.5% |
| 営業利益率 | 16.7% | -3.4% |
| 純利益率 | 9.5% | -17.5% |
| 売上前年比 | 9.9% | 5.6% |
| 純利益前年比 | 20.8% | -407.4% |
| EPS（希薄化後） | $1.43 | $-1.63 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $1.5B | $3.0B | ||
| Q3 25 | $1.5B | $3.5B | ||
| Q2 25 | $1.5B | $3.0B | ||
| Q1 25 | $1.5B | $2.6B | ||
| Q4 24 | $1.4B | $2.8B | ||
| Q3 24 | $1.4B | $2.8B | ||
| Q2 24 | $1.3B | $2.8B | ||
| Q1 24 | $1.3B | $2.7B |
| Q4 25 | $146.1M | $-519.5M | ||
| Q3 25 | $126.5M | $411.4M | ||
| Q2 25 | $142.1M | $410.7M | ||
| Q1 25 | $151.5M | $238.1M | ||
| Q4 24 | $120.9M | $169.0M | ||
| Q3 24 | $108.2M | $122.2M | ||
| Q2 24 | $114.1M | $-161.5M | ||
| Q1 24 | $112.5M | $45.2M |
| Q4 25 | — | 11.5% | ||
| Q3 25 | — | 16.0% | ||
| Q2 25 | — | 17.3% | ||
| Q1 25 | — | 18.6% | ||
| Q4 24 | — | 10.7% | ||
| Q3 24 | — | 14.8% | ||
| Q2 24 | — | 14.0% | ||
| Q1 24 | — | 14.9% |
| Q4 25 | 16.7% | -3.4% | ||
| Q3 25 | 14.9% | 9.8% | ||
| Q2 25 | 16.2% | 8.1% | ||
| Q1 25 | 16.4% | 12.9% | ||
| Q4 24 | 14.3% | 3.5% | ||
| Q3 24 | 13.6% | 4.1% | ||
| Q2 24 | 14.3% | 8.3% | ||
| Q1 24 | 13.6% | 6.5% |
| Q4 25 | 9.5% | -17.5% | ||
| Q3 25 | 8.6% | 11.9% | ||
| Q2 25 | 9.7% | 13.7% | ||
| Q1 25 | 10.4% | 9.1% | ||
| Q4 24 | 8.6% | 6.0% | ||
| Q3 24 | 8.0% | 4.3% | ||
| Q2 24 | 8.8% | -5.7% | ||
| Q1 24 | 8.5% | 1.7% |
| Q4 25 | $1.43 | $-1.63 | ||
| Q3 25 | $1.24 | $1.29 | ||
| Q2 25 | $1.39 | $1.29 | ||
| Q1 25 | $1.48 | $0.75 | ||
| Q4 24 | $1.18 | $0.53 | ||
| Q3 24 | $1.06 | $0.38 | ||
| Q2 24 | $1.12 | $-0.50 | ||
| Q1 24 | $1.10 | $0.14 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $72.2M | $276.6M |
| 総負債低いほど良い | $2.4B | $4.3B |
| 株主資本純資産 | $2.4B | $12.1B |
| 総資産 | $7.1B | $24.5B |
| 負債/資本比率低いほどレバレッジが低い | 1.00× | 0.35× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $72.2M | $276.6M | ||
| Q3 25 | $48.7M | $153.3M | ||
| Q2 25 | $99.1M | $286.2M | ||
| Q1 25 | $95.8M | $259.2M | ||
| Q4 24 | $85.4M | $272.8M | ||
| Q3 24 | $147.8M | $301.6M | ||
| Q2 24 | $154.4M | $322.0M | ||
| Q1 24 | $134.4M | $336.7M |
| Q4 25 | $2.4B | $4.3B | ||
| Q3 25 | $2.4B | $3.4B | ||
| Q2 25 | $2.3B | $3.3B | ||
| Q1 25 | $2.3B | $3.3B | ||
| Q4 24 | $2.4B | $3.3B | ||
| Q3 24 | $2.3B | $3.2B | ||
| Q2 24 | $2.7B | $3.2B | ||
| Q1 24 | $2.7B | $3.2B |
| Q4 25 | $2.4B | $12.1B | ||
| Q3 25 | $2.4B | $12.8B | ||
| Q2 25 | $2.3B | $12.4B | ||
| Q1 25 | $2.2B | $11.8B | ||
| Q4 24 | $2.1B | $11.5B | ||
| Q3 24 | $2.0B | $11.8B | ||
| Q2 24 | $1.8B | $11.7B | ||
| Q1 24 | $1.7B | $12.0B |
| Q4 25 | $7.1B | $24.5B | ||
| Q3 25 | $6.9B | $24.7B | ||
| Q2 25 | $6.8B | $24.3B | ||
| Q1 25 | $6.6B | $23.2B | ||
| Q4 24 | $6.5B | $22.9B | ||
| Q3 24 | $6.5B | $23.3B | ||
| Q2 24 | $6.4B | $22.6B | ||
| Q1 24 | $6.2B | $22.9B |
| Q4 25 | 1.00× | 0.35× | ||
| Q3 25 | 1.01× | 0.26× | ||
| Q2 25 | 1.02× | 0.27× | ||
| Q1 25 | 1.08× | 0.28× | ||
| Q4 24 | 1.14× | 0.29× | ||
| Q3 24 | 1.20× | 0.27× | ||
| Q2 24 | 1.46× | 0.27× | ||
| Q1 24 | 1.54× | 0.27× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $346.0M | $-56.1M |
| フリーキャッシュフロー営業CF - 設備投資 | $116.7M | $-405.7M |
| FCFマージンFCF / 売上 | 7.6% | -13.6% |
| 設備投資強度設備投資 / 売上 | 14.8% | 11.8% |
| キャッシュ転換率営業CF / 純利益 | 2.37× | — |
| 直近12ヶ月FCF直近4四半期 | $439.2M | $-534.6M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $346.0M | $-56.1M | ||
| Q3 25 | $270.8M | $228.5M | ||
| Q2 25 | $270.2M | $609.5M | ||
| Q1 25 | $288.6M | $42.9M | ||
| Q4 24 | $278.8M | $219.3M | ||
| Q3 24 | $267.8M | $312.9M | ||
| Q2 24 | $217.4M | $847.0M | ||
| Q1 24 | $238.8M | $-80.0M |
| Q4 25 | $116.7M | $-405.7M | ||
| Q3 25 | $83.7M | $-135.9M | ||
| Q2 25 | $113.3M | $304.9M | ||
| Q1 25 | $125.5M | $-297.9M | ||
| Q4 24 | $80.1M | $-74.8M | ||
| Q3 24 | $120.3M | $72.1M | ||
| Q2 24 | $60.5M | $513.1M | ||
| Q1 24 | $99.4M | $-463.0M |
| Q4 25 | 7.6% | -13.6% | ||
| Q3 25 | 5.7% | -3.9% | ||
| Q2 25 | 7.8% | 10.1% | ||
| Q1 25 | 8.6% | -11.4% | ||
| Q4 24 | 5.7% | -2.7% | ||
| Q3 24 | 8.9% | 2.6% | ||
| Q2 24 | 4.6% | 18.2% | ||
| Q1 24 | 7.6% | -17.3% |
| Q4 25 | 14.8% | 11.8% | ||
| Q3 25 | 12.7% | 10.6% | ||
| Q2 25 | 10.8% | 10.1% | ||
| Q1 25 | 11.2% | 13.0% | ||
| Q4 24 | 14.1% | 10.4% | ||
| Q3 24 | 10.9% | 8.6% | ||
| Q2 24 | 12.1% | 11.9% | ||
| Q1 24 | 10.6% | 14.3% |
| Q4 25 | 2.37× | — | ||
| Q3 25 | 2.14× | 0.56× | ||
| Q2 25 | 1.90× | 1.48× | ||
| Q1 25 | 1.90× | 0.18× | ||
| Q4 24 | 2.31× | 1.30× | ||
| Q3 24 | 2.48× | 2.56× | ||
| Q2 24 | 1.91× | — | ||
| Q1 24 | 2.12× | -1.77× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
MOS
セグメントデータなし
